Report Content

Chapter 1.  Methodology

1.1. Market definitions

1.2. Forecast assumptions

1.3. Data sources

1.3.1.  Secondary

1.3.1.1. Paid sources

1.3.1.2.    Unpaid sources

1.3.2.  Primary

Chapter 2.  Market Summary

2.1. Asia Pacific electrophysiology industry summary, 2016 – 2027

2.1.1.  Country trends

2.1.2.  Product trends

2.1.3.  Indication trends

2.1.4.  End-use trends

Chapter 3.  Market Analysis

3.1. Industry segmentation

3.2. Industry outlook, 2016 – 2027 (USD Million)

3.3. Major factor analysis

3.3.1.  Drivers

3.3.1.1.  Increasing prevalence of atrial fibrillation in the region

3.3.1.2.    Technological advancements in electrophysiology devices

3.3.1.3.    Growing penetration of market players

3.3.1.4.  Increasing awareness and preference for electrophysiology catheter ablation

3.3.2.  Restraints & challenges

3.3.2.1.  High investment for electrophysiology devices

3.3.2.2.    Dearth of skilled professionals in emerging nations

3.4. Analysis of COVID-19 impact on the industry

3.5. Porter’s analysis

3.6. Competitive review, 2020

3.7. PEST analysis

Chapter 4. Asia Pacific Electrophysiology Market Size, By Product

4.1. Market trends

4.2. EP ablation catheters

4.2.1.  Market size, by region, 2016-2027 (USD Million)

4.2.2.  Radiofrequency (RF) ablation catheters

4.2.2.1.  Market size, by region, 2016-2027 (USD Million)

4.2.3.  Cryoablation catheters

4.2.3.1.  Market size, by region, 2016-2027 (USD Million)

4.2.4.  Laser

4.2.4.1.  Market size, by region, 2016-2027 (USD Million)

4.2.5.  Others

4.2.5.1.  Market size, by region, 2016-2027 (USD Million)

4.3. EP diagnostic catheters

4.3.1.  Market size, by region, 2016-2027 (USD Million)

4.3.2.  Conventional

4.3.2.1.  Market size, by region, 2016-2027 (USD Million)

4.3.3.  Advanced

4.3.3.1.  Market size, by region, 2016-2027 (USD Million)

4.3.4.  Ultrasound

4.3.4.1.  Market size, by region, 2016-2027 (USD Million)

4.4. EP laboratory devices

4.4.1.  Market size, by region, 2016-2027 (USD Million)

4.4.2.  Mapping systems

4.4.2.1.    Market size, by region, 2016-2027 (USD Million)

4.4.3.  Recording systems

4.4.3.1.    Market size, by region, 2016-2027 (USD Million)

4.4.4.  Others

4.4.4.1.    Market size, by region, 2016-2027 (USD Million)

Chapter 5. Asia Pacific Electrophysiology Market Share, By Indication

5.1. Ventricular tachycardia

5.1.1.  Market size, by country, 2016-2027 (USD Million)

5.2. Atrial fibrillation

5.2.1.  Market size, by country, 2016-2027 (USD Million)

5.3. Atrial tachycardia

5.3.1.  Market size, by country, 2016-2027 (USD Million)

5.4. Atrial flutter

5.4.1.  Market size, by country, 2016-2027 (USD Million)

5.5. WOLFF-Parkinson-White (WPW) syndrome

5.5.1.  Market size, by country, 2016-2027 (USD Million)

5.6. Atrioventricular nodal re-entry tachycardia

5.6.1.  Market size, by country, 2016-2027 (USD Million)

Chapter 6. Asia Pacific Electrophysiology Market Trends, By End-use

6.1. Market trends

6.2. Hospitals

6.2.1.  Market size, by country, 2016-2027 (USD Million)

6.3. Catheterization laboratories/EP laboratories

6.3.1.  Market size, by country, 2016-2027 (USD Million)

6.4. Ambulatory surgical centers

6.4.1.  Market size, by country, 2016-2027 (USD Million)

6.5. Others

6.5.1.  Market size, by country, 2016-2027 (USD Million)

Chapter 7. Asia Pacific Electrophysiology Market Growth, By Country

7.1. Market trends

7.2. China

7.2.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.2.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.2.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.2.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.2.2.   Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.2.3.  Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

7.3. Japan

7.3.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.3.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.3.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.3.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.3.2.   Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.3.3.  Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

7.4. India

7.4.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.4.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.4.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.4.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.4.2.   Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.4.3.  Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

7.5. Australia

7.5.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.5.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.5.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.5.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.5.2.   Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.5.3.  Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

7.6. South Korea

7.6.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.6.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.6.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.6.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.6.2.   Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.6.3.  Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

7.7. Malaysia

7.7.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.7.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.7.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.7.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.7.2.   Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.7.3.  Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

7.8. Indonesia

7.8.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.8.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.8.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.8.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.8.2.   Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.8.3.  Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

7.9. Thailand

7.9.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.9.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.9.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.9.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.9.2.   Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.9.3.  Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

7.10.   Singapore

7.10.1. Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.10.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.10.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.10.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.10.2. Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.10.3.          Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

7.11.   Taiwan

7.11.1. Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.11.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.11.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.11.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.11.2. Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.11.3.          Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

7.12.   Philippines

7.12.1. Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.12.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.12.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.12.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.12.2. Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.12.3.          Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

7.13.   Vietnam

7.13.1. Market estimates and forecast, by product, 2016 – 2027 (USD Million)

7.13.1.1.  Market estimates and forecast, by EP ablation catheters, 2016 – 2027 (USD Million)

7.13.1.2.  Market estimates and forecast, by EP diagnostic catheters, 2016 – 2027 (USD Million)

7.13.1.3.  Market estimates and forecast, by EP laboratory devices, 2016 – 2027 (USD Million)

7.13.2. Market estimates and forecast, by indication, 2016 – 2027 (USD Million)

7.13.3.          Market estimates and forecast, by end-use, 2016 – 2027 (USD Million)

Chapter 8.  Company Profiles

8.1. Abbott Laboratories

8.1.1.  Business overview

8.1.2.  Financial data

8.1.3.  Product landscape

8.1.4.  Strategic outlook

8.1.5.  SWOT analysis

8.2. Biotronik SE & Co. KG

8.2.1.  Business overview

8.2.2.  Financial data

8.2.3.  Product landscape

8.2.4.  Strategic outlook

8.2.5.  SWOT analysis

8.3. Boston Scientific Corporation

8.3.1.  Business overview

8.3.2.  Financial data

8.3.3.  Product landscape

8.3.4.  Strategic outlook

8.3.5.  SWOT analysis

8.4. GE Healthcare

8.4.1.  Business overview

8.4.2.  Financial data

8.4.3.  Product landscape

8.4.4.  Strategic outlook

8.4.5.  SWOT analysis

8.5. Japan Lifeline

8.5.1.  Business overview

8.5.2.  Financial data

8.5.3.  Product landscape

8.5.4.  Strategic outlook

8.5.5.  SWOT analysis

8.6. Johnson & Johnson

8.6.1.  Business overview

8.6.2.  Financial data

8.6.3.  Product landscape

8.6.4.  Strategic outlook

8.6.5.  SWOT analysis

8.7. Koninklijke Philips

8.7.1.  Business overview

8.7.2.  Financial data

8.7.3.  Product landscape

8.7.4.  Strategic outlook

8.7.5.  SWOT analysis

8.8. Medtronic

8.8.1.  Business overview

8.8.2.  Financial data

8.8.3.  Product landscape

8.8.4.  Strategic outlook

8.8.5.  SWOT analysis

8.9. Microport Scientific Corporation

8.9.1.  Business overview

8.9.2.  Financial data

8.9.3.  Product landscape

8.9.4.  Strategic outlook

8.9.5.  SWOT analysis

8.10.  Magnetecs Corporation

8.10.1. Business overview

8.10.2.          Financial data

8.10.3.          Product landscape

8.10.4.          Strategic outlook

8.10.5.          SWOT analysis

8.11.    Siemens AG

8.11.1. Business overview

8.11.2.          Financial data

8.11.3.          Product landscape

8.11.4.          Strategic outlook

8.11.5.          SWOT analysis

8.12.    Stereotaxis

8.12.1. Business overview

8.12.2.          Financial data

8.12.3.          Product landscape

8.12.4.          Strategic outlook

8.12.5.          SWOT analysis

8.13.    Topera Medical

8.13.1. Business overview

8.13.2.          Financial data

8.13.3.          Product landscape

8.13.4.          Strategic outlook

8.13.5.          SWOT analysis